17beta-estradiol multiple interactions ISO RGD:1314439 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of FHOD3 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314439 6480464 Tetrachlorodibenzodioxin results in increased expression of FHOD3 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1621343 6480464 Tetrachlorodibenzodioxin affects the expression of FHOD3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1621343 6480464 Tetrachlorodibenzodioxin results in decreased expression of FHOD3 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1621343 6480464 Tetrachlorodibenzodioxin results in increased expression of FHOD3 mRNA CTD PMID:19465110 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 4,4'-sulfonyldiphenol increases methylation ISO RGD:1621343 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of FHOD3 exon CTD PMID:33297965 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1314439 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of FHOD3 gene CTD PMID:31601247 4,4'-sulfonyldiphenol affects methylation ISO RGD:1314439 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of FHOD3 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO RGD:1621343 6480464 Fenretinide results in increased expression of FHOD3 mRNA CTD PMID:28973697 7,12-dimethyltetraphene decreases expression ISO RGD:1621343 6480464 9 more ... CTD PMID:32553695 aconitine increases expression EXP 6480464 Aconitine results in increased expression of FHOD3 protein CTD PMID:33236894 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of FHOD3 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:1621343 6480464 Aflatoxin B1 results in decreased expression of FHOD3 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1314439 6480464 Aflatoxin B1 results in decreased methylation of FHOD3 promoter CTD PMID:30157460 aflatoxin B1 affects methylation ISO RGD:1314439 6480464 Aflatoxin B1 affects the methylation of FHOD3 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:1314439 6480464 Aflatoxin B1 results in decreased expression of FHOD3 mRNA CTD PMID:22100608 , PMID:32234424 Aflatoxin B2 alpha affects methylation ISO RGD:1314439 6480464 aflatoxin B2 affects the methylation of FHOD3 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1314439 6480464 Tretinoin results in decreased expression of FHOD3 mRNA CTD PMID:21934132 antirheumatic drug increases expression ISO RGD:1314439 6480464 Antirheumatic Agents results in increased expression of FHOD3 mRNA CTD PMID:24449571 aristolochic acid decreases expression ISO RGD:1314439 6480464 aristolochic acid I results in decreased expression of FHOD3 mRNA CTD PMID:33212167 benzo[a]pyrene decreases expression ISO RGD:1621343 6480464 Benzo(a)pyrene results in decreased expression of FHOD3 mRNA CTD PMID:19770486 , PMID:20713471 benzo[a]pyrene decreases expression ISO RGD:1314439 6480464 Benzo(a)pyrene results in decreased expression of FHOD3 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1314439 6480464 Benzo(a)pyrene affects the methylation of FHOD3 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1621343 6480464 Benzo(a)pyrene results in increased methylation of FHOD3 intron CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1314439 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene decreases expression ISO RGD:1621343 6480464 benzo(b)fluoranthene results in decreased expression of FHOD3 mRNA CTD PMID:26377693 benzo[e]pyrene affects methylation ISO RGD:1314439 6480464 benzo(e)pyrene affects the methylation of FHOD3 intron CTD PMID:30157460 bisphenol A decreases expression ISO RGD:1621343 6480464 bisphenol A results in decreased expression of FHOD3 mRNA CTD PMID:26063408 bisphenol A affects methylation ISO RGD:1314439 6480464 bisphenol A affects the methylation of FHOD3 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1314439 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of FHOD3 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1314439 6480464 bisphenol A results in decreased expression of FHOD3 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FHOD3 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FHOD3 mRNA CTD PMID:25181051 , PMID:34947998 calcitriol increases expression ISO RGD:1314439 6480464 Calcitriol results in increased expression of FHOD3 mRNA CTD PMID:16002434 carbon nanotube decreases expression ISO RGD:1621343 6480464 Nanotubes, Carbon results in decreased expression of FHOD3 mRNA CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:1314439 6480464 CGP 52608 promotes the reaction [RORA protein binds to FHOD3 gene] CTD PMID:28238834 cisplatin decreases expression ISO RGD:1314439 6480464 Cisplatin results in decreased expression of FHOD3 mRNA CTD PMID:19561079 cisplatin multiple interactions ISO RGD:1314439 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of FHOD3 mRNA CTD PMID:27392435 dibutyl phthalate increases expression ISO RGD:1621343 6480464 Dibutyl Phthalate results in increased expression of FHOD3 mRNA CTD PMID:21266533 dioxygen decreases expression ISO RGD:1621343 6480464 Oxygen deficiency results in decreased expression of FHOD3 mRNA CTD PMID:20880076 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FHOD3 mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1314439 6480464 Doxorubicin results in decreased expression of FHOD3 mRNA CTD PMID:29803840 elemental selenium decreases expression ISO RGD:1314439 6480464 Selenium results in decreased expression of FHOD3 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FHOD3 mRNA CTD PMID:29391264 ethanol affects expression ISO RGD:1621343 6480464 Ethanol affects the expression of FHOD3 mRNA CTD PMID:30319688 fulvestrant decreases methylation ISO RGD:1314439 6480464 Fulvestrant results in decreased methylation of FHOD3 gene CTD PMID:31601247 fulvestrant multiple interactions ISO RGD:1314439 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of FHOD3 gene, [bisphenol A co-treated with Fulvestrant] affects the methylation of FHOD3 gene CTD PMID:31601247 lead(0) affects splicing ISO RGD:1314439 6480464 Lead affects the splicing of FHOD3 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1314439 6480464 Lead affects the splicing of FHOD3 mRNA CTD PMID:28903495 leflunomide decreases expression ISO RGD:1314439 6480464 leflunomide results in decreased expression of FHOD3 mRNA CTD PMID:28988120 mercury dibromide decreases expression ISO RGD:1314439 6480464 mercuric bromide results in decreased expression of FHOD3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA CTD PMID:27188386 methapyrilene affects methylation ISO RGD:1314439 6480464 Methapyrilene affects the methylation of FHOD3 intron CTD PMID:30157460 methyl methanesulfonate decreases expression ISO RGD:1314439 6480464 Methyl Methanesulfonate results in decreased expression of FHOD3 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1314439 6480464 methylmercuric chloride results in decreased expression of FHOD3 mRNA CTD PMID:28001369 nickel atom decreases expression ISO RGD:1314439 6480464 Nickel results in decreased expression of FHOD3 mRNA CTD PMID:24768652 , PMID:25583101 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of FHOD3 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:1314439 6480464 methyleugenol results in decreased expression of FHOD3 mRNA CTD PMID:32234424 p-chloromercuribenzoic acid decreases expression ISO RGD:1314439 6480464 p-Chloromercuribenzoic Acid results in decreased expression of FHOD3 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:1314439 6480464 panobinostat results in decreased expression of FHOD3 mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:1314439 6480464 Acetaminophen results in decreased expression of FHOD3 mRNA CTD PMID:22230336 phenylmercury acetate decreases expression ISO RGD:1314439 6480464 Phenylmercuric Acetate results in decreased expression of FHOD3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA CTD PMID:27188386 potassium chromate increases expression ISO RGD:1314439 6480464 potassium chromate(VI) results in increased expression of FHOD3 mRNA CTD PMID:22714537 progesterone decreases expression ISO RGD:1314439 6480464 Progesterone results in decreased expression of FHOD3 mRNA CTD PMID:20864642 propanal increases expression ISO RGD:1314439 6480464 propionaldehyde results in increased expression of FHOD3 mRNA CTD PMID:26079696 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1314439 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of FHOD3 mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO RGD:1314439 6480464 Selenium results in decreased expression of FHOD3 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:1314439 6480464 Silicon Dioxide results in decreased expression of FHOD3 mRNA CTD PMID:25351596 silver atom decreases expression ISO RGD:1621343 6480464 Silver results in decreased expression of FHOD3 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1621343 6480464 Silver results in decreased expression of FHOD3 mRNA CTD PMID:27131904 sulforaphane increases expression ISO RGD:1621343 6480464 sulforaphane results in increased expression of FHOD3 mRNA CTD PMID:30529165 tert-butyl hydroperoxide increases expression ISO RGD:1314439 6480464 tert-Butylhydroperoxide results in increased expression of FHOD3 mRNA CTD PMID:15336504 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of FHOD3 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1314439 6480464 trichostatin A results in decreased expression of FHOD3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1314439 6480464 Triclosan results in decreased expression of FHOD3 mRNA CTD PMID:30510588 valproic acid increases methylation ISO RGD:1314439 6480464 Valproic Acid results in increased methylation of FHOD3 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1314439 6480464 Valproic Acid results in increased expression of FHOD3 mRNA CTD PMID:23179753 valproic acid decreases expression ISO RGD:1314439 6480464 Valproic Acid results in decreased expression of FHOD3 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA CTD PMID:27188386 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of FHOD3 gene CTD PMID:31079544 vorinostat multiple interactions ISO RGD:1314439 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:1314439 6480464 vorinostat results in decreased expression of FHOD3 mRNA CTD PMID:26272509 XL147 multiple interactions ISO RGD:1621343 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FHOD3 mRNA] CTD PMID:29891994